Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Events

08 Dec 2026 - 10 Dec 2026
25 Jan 2027 - 28 Jan 2027

Ultra-Portable Device Enables Finger-Prick Blood Testing at Home

By HospiMedica International staff writers
Posted on 07 Aug 2026

Patients who need frequent blood tests often face repeated clinic visits that burden services and disrupt care. More...

In the UK, millions of tests are performed each year to diagnose disease, guide therapy, and track health, yet results usually capture a single moment. Home-based, longitudinal testing could highlight small physiologic changes and reduce travel for vulnerable groups such as people on chemotherapy.

King’s College London spinout Algocyte has introduced the Algocyte PROXIMA Mobile Health Station (MHS), an ultra‑portable blood testing device designed and manufactured in the UK. The instrument is intended for use by non‑specialist providers, including nurses, general practitioners, pharmacists, and care‑home staff. It uses a small finger‑prick sample and connects over Bluetooth to deliver results that can be shared with clinicians and patients on the spot, building a longitudinal picture of health.

The system combines two independent sensing technologies with a physics‑informed artificial intelligence (AI) approach. Its hybrid architecture integrates complementary deep‑learning models, including convolutional neural networks and Vision Transformers, and uses a quantum‑inspired aggregation inference method. By incorporating measurement redundancy and cross‑validating multiple sensing modalities, the device enables measurement of 12 biomarkers that comprise a Full Blood Count (FBC). It can operate via a mobile phone, run from a compact external power bank, and has been tested across Ethernet, Wi‑Fi, 5G, and 4G hotspots. According to the company, applications include conditions such as anemia, infection, inflammation, and cancer.

The device has achieved the UKCA mark as a UK in vitro diagnostics (IVD) General Class instrument and is progressing through further testing and evaluation in commercial deployment while gathering additional scientific evidence and completing further regulatory steps. The Algocyte PROXIMA MHS was launched on June 29 at the Royal Society of Medicine in London, where live demonstrations were accompanied by an immersive virtual‑reality training platform that simulates the complete workflow on Apple Vision Pro. The company reports ongoing pilots in early stages in the UK, Canada, and the United Arab Emirates, including feedback from National Health Service laboratorists and evaluation in a Canadian government rural community hub.

“This achievement demonstrates how academia and industry can work together to deliver meaningful social impact. Academia advances fundamental research into health, disease, and the application of AI to cell and molecular biology. Industry translates these advances into scalable technologies. This technology could have a real‑world impact on the many patients receiving treatments that would benefit from regular blood monitoring, such as chemotherapy or the use of medicines like clozapine, which require close monitoring of blood cell levels due to potential side effects or complications,” said Dr. Hector Zenil, founder and CEO of Algocyte, and Associate Professor in Healthcare Engineering at King’s College London.

Related Links
Algocyte


Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Hand-held Hemoglobin Analyzer
DiaSpect Tm
Wound Irrigation Solution
Prontosan®
Syringe Pump
SP50 Series
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Artificial Intelligence

view channel
Image: Design-science framework integrating CML and LLM pipelines for supply chain risk evaluation. (Gupta I, Konduru H, Correa S, et al. A causal analytics approach for interpretable supply chain risk and supplier performance evaluation. Supply Chain Analytics, 2026. doi:10.1016/j.sca.2026.100248)

Causal AI Tool Withholds Ovarian Cancer Treatment Recommendations When Evidence Insufficient

Ovarian cancer treatment often requires individualized decisions, particularly when available patient data do not clearly favor one therapeutic approach. However, artificial intelligence (AI) systems may... Read more

Patient Care

view channel
Image: A view inside the custom virtual reality environment used in the study: a calm room with a teddy bear, soft colors and large windows looking out over the sea. (Image Credit: Walaa S. Abu Rukbah et al., Virginia Commonwealth University; CC-BY 4.0, https://creativecommons.org/licenses/by/4.0/)

Virtual Reality Program May Reduce Anxiety Before Pediatric Surgery

Presurgery anxiety affects an estimated 50% to 75% of children undergoing surgery and can complicate anesthesia induction, increase postoperative pain, and prolong recovery. Sedation is often used to manage... Read more

Medical Imaging

view channel
Image: Overview of the study design, including participant recruitment, multimodal neuroimaging analysis, stage- and cognition-informed feature selection, and development and validation of the DBFG-Net model. CKD-CI, CKD with cognitive impairment; CKD-NCI, CKD without cognitive impairment; HCs, healthy controls; CBF, cerebral blood flow; DBFG-Net, Dual-Branch Feature-Gated Network. (Photo courtesy of Wenbo Yang and Lijun Song, Capital Medical University)

AI Combines Brain Imaging Features to Identify Cognitive Impairment in CKD

Chronic kidney disease (CKD) can affect multiple organs, including the brain, with cognitive impairment emerging as a common complication. Changes in executive function, attention, and memory can reduce... Read more

Health IT

view channel
Image Credit: Shutterstock

Telemonitoring Program Improves Quality of Life After Heart Failure Discharge

Heart failure is a chronic condition associated with high mortality, frequent hospitalizations, and reduced quality of life. Patients face particularly high risks of readmission and death after discharge,... Read more

Point of Care

view channel
Image: Jessica Ramella-Roman, professor of biomedical engineering at Florida International University, holding the PPRIM (Portable Preterm Imaging) device designed to detect early signs of preterm labor risk. (Photo courtesy of Florida International University)

Handheld Imaging Device May Help Identify Preterm Birth Risk Earlier

Preterm birth, defined as delivery before 37 weeks of pregnancy, can lead to serious neonatal complications, including neurological, developmental, and respiratory problems. However, identifying pregnancies... Read more

Business

view channel
Image: Stryker has acquired ZuriMED, adding the FiberLocker System, a rotator cuff augmentation technology designed to strengthen repairs, to its Sports Medicine portfolio. (Photo courtesy of ZuriMED)

Stryker Completes Acquisition to Broaden Shoulder Surgery Offerings

Stryker (Portage, MI, USA) has completed its acquisition of ZuriMED (Zurich, Switzerland), a privately held developer of the FiberLocker System, expanding its Sports Medicine portfolio with a commercialized... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.